Greater occipital nerve blockade for the preventive treatment of chronic migraine: A randomized double-blind placebo-controlled study.

Debashish ChowdhuryApoorva TomarVaibhav DeorariAshish DuggalAnand KrishnanArun Koul

Published in: Cephalalgia : an international journal of headache (2023)

Four-weekly greater occipital nerve blockade with 2% lidocaine for 12 weeks was superior to placebo in decreasing the average number of headache and migraine days in patients with chronic migraine with a good tolerability profile.Clinical trial.gov no. CTRI 2020/07/026709.

Keyphrases

double blind
clinical trial
placebo controlled
phase iii
phase ii
study protocol
open label
peripheral nerve
randomized controlled trial
drug induced